ZA200701531B - Prevention and treatment of synucleinopathic and amyloidogenic disease - Google Patents

Prevention and treatment of synucleinopathic and amyloidogenic disease

Info

Publication number
ZA200701531B
ZA200701531B ZA200701531A ZA200701531A ZA200701531B ZA 200701531 B ZA200701531 B ZA 200701531B ZA 200701531 A ZA200701531 A ZA 200701531A ZA 200701531 A ZA200701531 A ZA 200701531A ZA 200701531 B ZA200701531 B ZA 200701531B
Authority
ZA
South Africa
Prior art keywords
synucleinopathic
prevention
treatment
amyloidogenic disease
amyloidogenic
Prior art date
Application number
ZA200701531A
Inventor
Dale B Schenk
Masliah Eliezer
Manuel J Buttini
Tamie J Chilcote
Rockenstein Edward
Games Kate Dora
Original Assignee
Elan Pharm Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/915,214 external-priority patent/US8697082B2/en
Application filed by Elan Pharm Inc, Univ California filed Critical Elan Pharm Inc
Publication of ZA200701531B publication Critical patent/ZA200701531B/en

Links

ZA200701531A 2004-08-09 2005-08-09 Prevention and treatment of synucleinopathic and amyloidogenic disease ZA200701531B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/915,214 US8697082B2 (en) 2002-11-01 2004-08-09 Prevention and treatment of synucleinopathic and amyloidogenic disease

Publications (1)

Publication Number Publication Date
ZA200701531B true ZA200701531B (en) 2009-03-25

Family

ID=38783447

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701531A ZA200701531B (en) 2004-08-09 2005-08-09 Prevention and treatment of synucleinopathic and amyloidogenic disease

Country Status (2)

Country Link
CN (1) CN101052417A (en)
ZA (1) ZA200701531B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101570575B (en) * 2008-04-30 2012-02-29 北京市肿瘤防治研究所 Sncg monoclonal antibody and application thereof
AT508638B1 (en) * 2009-08-21 2011-08-15 Affiris Ag USE OF PEPTIDES AND POLYPEPTIDES FOR THE TREATMENT AND / OR PREVENTION OF SYNNUCLEOPATHIES
CN101692092B (en) * 2009-09-24 2013-04-10 首都医科大学宣武医院 Method for quantitatively detecting alpha-synuclein auto-antibodies in human sera
CN103443277B (en) * 2011-02-18 2016-02-24 国立大学法人东京农工大学 Amyloid oligopolymer bind nucleic acid is fit
CN103320391A (en) * 2013-07-12 2013-09-25 首都医科大学 Hybridoma cell and application thereof
AU2014351996B2 (en) * 2013-11-21 2020-01-02 F. Hoffmann-La Roche Ag Anti-alpha-synuclein antibodies and methods of use
CA3003841A1 (en) * 2015-11-30 2017-06-08 Universitat Wien Compound for use in the prevention and treatment of neurodegenerative diseases
KR102593669B1 (en) * 2016-11-15 2023-10-25 하. 룬드벡 아크티에셀스카브 Agents, uses and methods for the treatment of synucleinopathies
CN112661828B (en) * 2021-01-15 2022-04-01 武汉大学 Antigen peptide of synapsin, antibody and application thereof

Also Published As

Publication number Publication date
CN101052417A (en) 2007-10-10

Similar Documents

Publication Publication Date Title
SI1793855T2 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
EP1910829A4 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
PL2118300T3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
AU2003290548A8 (en) Prevention and treatment of synucleinopathic disease
HK1108168A1 (en) Vaccine for prevention and treatment of hiv-infection
EP1968607A4 (en) Treatment of cancer and other diseases
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
ZA200701531B (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1865972A4 (en) Treatment or prevention of cancer and precancerous disorders
EP1789047A4 (en) Treatment of diseases using nalmefene and its analgos
HK1184169A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
EP1817039A4 (en) Treatment and prevention of epilepsy
GB0320238D0 (en) Treatment of disease
EP1773882A4 (en) Diagnosis and treatment of siglec-6 associated diseases
GB2441094B (en) Methods for treatment and prevention of infection
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
GB0414428D0 (en) Compounds and methods of treatment
GB0407710D0 (en) Treatment of diseases
GB201010682D0 (en) Methods for treatment and prevention of infection
GB0510257D0 (en) Methods for treatment and prevention of infection
GB0612749D0 (en) Treatment and/or prevention of pain